• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Star Equity Holdings to Release Second Quarter 2025 Financial Results on August 13

    8/4/25 8:30:30 AM ET
    $STRR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care
    Get the next $STRR alert in real time by email

    OLD GREENWICH, Conn., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Star Equity Holdings, Inc. (NASDAQ:STRR, STRRP)), ("Star Equity" or the "Company"), a diversified holding company, announced today that it will release its financial results for the second quarter ended June 30, 2025, before the market opens on Wednesday, August 13, 2025.

    A conference call is scheduled for 10:00 a.m. ET (7:00 a.m. PT) on August 13, 2025, to discuss the results and management's outlook. The call may be accessed by dialing:

    • Toll Free: 1-833-630-1956
    • International: 1-412-317-1837



    A simultaneous webcast of the call may be accessed online from the Events & Presentations link, on the Investor Relations page of the Star Equity website at: https://www.starequity.com/events-and-presentations/presentations.

    An archived replay of the webcast will be available shortly after the end of the conference call.

    About Star Equity Holdings, Inc.

    Star Equity Holdings, Inc. is a diversified holding company currently composed of three business divisions: Building Solutions, Energy Services, and Investments.

    Building Solutions

    Our Building Solutions division operates in three businesses: (i) modular building manufacturing; (ii) structural wall panel and wood foundation manufacturing, including building supply distribution operations; and (iii) glue-laminated timber (glulam) column, beam, and truss manufacturing.

    Energy Services

    Our Energy Services division engages in the rental, sale, and repair of downhole tools used in the oil and gas, geothermal, mining, and water-well industries.

    Investments

    Our Investments division manages and finances the Company's real estate assets as well as its investment positions in private and public companies.

    For more information contact: 
    Star Equity Holdings, Inc.The Equity Group
    Rick ColemanLena Cati
    CEOSenior Vice President
    203-489-9508212-836-9611
    [email protected][email protected]



    Primary Logo

    Get the next $STRR alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $STRR

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $STRR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Coleman Richard Kenneth Jr. bought $10,675 worth of shares (2,500 units at $4.27) and bought $4,925 worth of 10% Series A Cumulative Perpetual Preferred Stock (500 units at $9.85), decreasing direct ownership by 93% to 2,500 units (SEC Form 4)

    4 - STAR EQUITY HOLDINGS, INC. (0000707388) (Issuer)

    8/20/24 4:10:35 PM ET
    $STRR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Butcher Thatcher bought $3,120 worth of shares (3,000 units at $1.04), increasing direct ownership by 100% to 6,000 units (SEC Form 4)

    4 - STAR EQUITY HOLDINGS, INC. (0000707388) (Issuer)

    12/15/23 1:41:36 PM ET
    $STRR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Coleman Richard Kenneth Jr. bought $2,220 worth of shares (2,000 units at $1.11) and bought $18,900 worth of 10% Series A Cumulative Perpetual Preferred Stock (2,000 units at $9.45), decreasing direct ownership by 98% to 2,000 units (SEC Form 4)

    4 - STAR EQUITY HOLDINGS, INC. (0000707388) (Issuer)

    12/4/23 8:25:38 PM ET
    $STRR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $STRR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Star Equity Holdings, Inc. Announces 2025 Second Quarter Financial Results

    Q2 2025 revenues increased ~76% to $23.7 million and gross profit increased ~182% to $6.3 million Generated Adjusted EBITDA of $7.0 million Quarter-end Building Solutions backlog stands at $25.7 million OLD GREENWICH, Conn., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Star Equity Holdings, Inc. (NASDAQ:STRR, STRRP)) ("Star" or the "Company"), a diversified holding company, reported today its financial results for the second quarter (Q2) ended June 30, 2025. All 2025 and 2024 amounts in this release are unaudited. Q2 2025 Financial Highlights vs. Q2 2024 (unaudited) Revenues increased by 75.8% to $23.7 million from $13.5 million.Gross profit increased by 182.2% to $6.3 million from $2.2 million.

    8/13/25 8:30:29 AM ET
    $HSON
    $STRR
    Professional Services
    Consumer Discretionary
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Star Equity Holdings, Inc. Declares a Partial Cash Dividend of $0.225 Per Share of 10% Series A Cumulative Perpetual Preferred Stock

    OLD GREENWICH, Conn., Aug. 08, 2025 (GLOBE NEWSWIRE) -- Star Equity Holdings, Inc. (NASDAQ:STRR, STRRP)) ("Star" or the "Company"), a diversified holding company, announced today that its Board of Directors declared a partial cash dividend to holders of the Company's 10% Series A Cumulative Perpetual Preferred Stock ("Star Preferred Stock") of $0.225 per share. The record date for this dividend is August 21, 2025 and the payment date is September 10, 2025. As previously disclosed, on May 21, 2025, Hudson Global, Inc., a Delaware corporation ("Hudson"), HSON Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Hudson ("Merger Sub"), and the Company, entered into

    8/8/25 5:15:31 PM ET
    $STRR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Hudson Global Reports 2025 Second Quarter Results

    OLD GREENWICH, Conn., Aug. 08, 2025 (GLOBE NEWSWIRE) -- Hudson Global, Inc. (NASDAQ:HSON) ("Hudson Global" or "the Company"), a leading global total talent solutions company, announced today financial results for the second quarter ended June 30, 2025. 2025 Second Quarter Summary Revenue of $35.5 million decreased 0.5% from the second quarter of 2024 and 0.2% in constant currency.Adjusted net revenue of $18.6 million increased 5.8% from the second quarter of 2024 and 5.1% in constant currency.Net loss was $0.7 million, or $0.23 per diluted share, compared to net loss of $0.4 million, or $0.15 per diluted share, for the second quarter of 2024. Adjusted net income per d

    8/8/25 8:30:45 AM ET
    $HSON
    $STRR
    Professional Services
    Consumer Discretionary
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $STRR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Director Palmer Jennifer

    4 - STAR EQUITY HOLDINGS, INC. (0000707388) (Issuer)

    8/18/25 7:24:27 PM ET
    $STRR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form 4 filed by Director Fruhbeis Todd Michael

    4 - STAR EQUITY HOLDINGS, INC. (0000707388) (Issuer)

    8/18/25 7:23:28 PM ET
    $STRR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form 4 filed by Director Parks Louis A.

    4 - STAR EQUITY HOLDINGS, INC. (0000707388) (Issuer)

    8/18/25 7:22:47 PM ET
    $STRR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $STRR
    Financials

    Live finance-specific insights

    View All

    Star Equity Holdings, Inc. Announces 2025 Second Quarter Financial Results

    Q2 2025 revenues increased ~76% to $23.7 million and gross profit increased ~182% to $6.3 million Generated Adjusted EBITDA of $7.0 million Quarter-end Building Solutions backlog stands at $25.7 million OLD GREENWICH, Conn., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Star Equity Holdings, Inc. (NASDAQ:STRR, STRRP)) ("Star" or the "Company"), a diversified holding company, reported today its financial results for the second quarter (Q2) ended June 30, 2025. All 2025 and 2024 amounts in this release are unaudited. Q2 2025 Financial Highlights vs. Q2 2024 (unaudited) Revenues increased by 75.8% to $23.7 million from $13.5 million.Gross profit increased by 182.2% to $6.3 million from $2.2 million.

    8/13/25 8:30:29 AM ET
    $HSON
    $STRR
    Professional Services
    Consumer Discretionary
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Hudson Global Reports 2025 Second Quarter Results

    OLD GREENWICH, Conn., Aug. 08, 2025 (GLOBE NEWSWIRE) -- Hudson Global, Inc. (NASDAQ:HSON) ("Hudson Global" or "the Company"), a leading global total talent solutions company, announced today financial results for the second quarter ended June 30, 2025. 2025 Second Quarter Summary Revenue of $35.5 million decreased 0.5% from the second quarter of 2024 and 0.2% in constant currency.Adjusted net revenue of $18.6 million increased 5.8% from the second quarter of 2024 and 5.1% in constant currency.Net loss was $0.7 million, or $0.23 per diluted share, compared to net loss of $0.4 million, or $0.15 per diluted share, for the second quarter of 2024. Adjusted net income per d

    8/8/25 8:30:45 AM ET
    $HSON
    $STRR
    Professional Services
    Consumer Discretionary
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Star Equity Holdings to Release Second Quarter 2025 Financial Results on August 13

    OLD GREENWICH, Conn., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Star Equity Holdings, Inc. (NASDAQ:STRR, STRRP)), ("Star Equity" or the "Company"), a diversified holding company, announced today that it will release its financial results for the second quarter ended June 30, 2025, before the market opens on Wednesday, August 13, 2025. A conference call is scheduled for 10:00 a.m. ET (7:00 a.m. PT) on August 13, 2025, to discuss the results and management's outlook. The call may be accessed by dialing: Toll Free: 1-833-630-1956International: 1-412-317-1837 A simultaneous webcast of the call may be accessed online from the Events & Presentations link, on the Investor Relations page of the Star Eq

    8/4/25 8:30:30 AM ET
    $STRR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $STRR
    SEC Filings

    View All

    Star Equity Holdings Inc. filed SEC Form 8-K: Other Events

    8-K - STAR EQUITY HOLDINGS, INC. (0000707388) (Filer)

    8/15/25 4:10:33 PM ET
    $STRR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form 10-Q filed by Star Equity Holdings Inc.

    10-Q - STAR EQUITY HOLDINGS, INC. (0000707388) (Filer)

    8/13/25 4:12:57 PM ET
    $STRR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Star Equity Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - STAR EQUITY HOLDINGS, INC. (0000707388) (Filer)

    8/13/25 8:44:18 AM ET
    $STRR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $STRR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Star Equity Holdings Inc.

    SC 13D/A - STAR EQUITY HOLDINGS, INC. (0000707388) (Subject)

    9/10/24 4:04:39 PM ET
    $STRR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form SC 13D/A filed by Star Equity Holdings Inc. (Amendment)

    SC 13D/A - STAR EQUITY HOLDINGS, INC. (0000707388) (Subject)

    9/18/23 4:05:02 PM ET
    $STRR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form SC 13D/A filed by Star Equity Holdings Inc. (Amendment)

    SC 13D/A - STAR EQUITY HOLDINGS, INC. (0000707388) (Subject)

    8/31/23 5:18:25 PM ET
    $STRR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $STRR
    Leadership Updates

    Live Leadership Updates

    View All

    Star Equity Holdings, Inc. Appoints Rick Coleman as CEO

    OLD GREENWICH, Conn., April 01, 2022 (GLOBE NEWSWIRE) -- Star Equity Holdings, Inc. (NASDAQ:STRR, STRRP))) ("Star Equity" or the "Company"), a diversified holding company, announced today the appointment of Richard ("Rick") K. Coleman, Jr. as Chief Executive Officer, effective April 1, 2022. In addition, Mr. Coleman will be nominated to serve as a director at the Company's upcoming annual meeting of shareholders. Mr. Coleman is a seasoned executive who brings to Star Equity extensive CEO leadership and board-level experience with numerous public and private companies. He was appointed as Star Equity's Chief Operating Officer in January 2022 and has provided valuable insights and direction

    4/1/22 8:00:00 AM ET
    $STRR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Star Equity Holdings, Inc. Adds Richard Coleman as Chief Operating Officer

    OLD GREENWICH, Conn., Dec. 20, 2021 (GLOBE NEWSWIRE) -- Star Equity Holdings, Inc. (NASDAQ:STRR, STRRP))) ("Star Equity" or the "Company"), a diversified holding company, announced today the appointment of Richard K. Coleman, Jr. ("Rick") as Chief Operating Officer, effective January 1, 2022. Coleman's addition increases the capacity of Star Equity's senior leadership team. In this role, he will oversee the Company's operations, assist its business leaders in achieving their growth and profitability goals, launch new business initiatives, as well as help analyze and integrate future acquisitions. Coleman brings more than 30 years of executive leadership experience with extensive expertis

    12/20/21 8:00:00 AM ET
    $STRR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Star Equity Holdings, Inc. Appoints John Gildea to its Board of Directors

    OLD GREENWICH, Conn., Aug. 06, 2021 (GLOBE NEWSWIRE) -- Star Equity Holdings, Inc. (NASDAQ:STRR, STRRP))) ("Star Equity" or the "Company"), a diversified, multi-industry holding company with three business divisions, Healthcare, Construction, and Investments, announced today the appointment of John W. Gildea to its Board of Directors, effective immediately. Mr. Gildea's appointment as independent director expands Star Equity's Board to six members. Mr. Gildea will also serve on the Audit Committee. Mr. Gildea brings over three decades of experience investing in special situation debt and equity of small to middle market companies. He is the founding partner of Gildea Management Co., a fir

    8/6/21 4:38:13 PM ET
    $STRR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care